MacEwen EG - Search Results

1

Therapy for osteosarcoma in dogs with intravenous injection of liposome-encapsulated muramyl tripeptide.

MacEwen EG, Kurzman ID, Rosenthal RC, Smith BW, Manley PA, Roush JK, Howard PE. MacEwen EG, et al. J Natl Cancer Inst. 1989 Jun 21;81(12):935-8. doi: 10.1093/jnci/81.12.935. J Natl Cancer Inst. 1989. PMID: 2733037

2

Effect of liposome-muramyl tripeptide combined with recombinant canine granulocyte colony-stimulating factor on canine monocyte activity.

Kurzman ID, Cheng H, MacEwen EG. Kurzman ID, et al. Among authors: macewen eg. Cancer Biother. 1994 Summer;9(2):113-21. doi: 10.1089/cbr.1994.9.113. Cancer Biother. 1994. PMID: 7529085

3

Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine for the treatment of feline mammary adenocarcinoma--a multicenter randomized double-blind study.

Fox LE, MacEwen EG, Kurzman ID, Dubielzig RR, Helfand SC, Vail DM, Kisseberth W, London C, Madewell BR, Rodriguez CO Jr. Fox LE, et al. Among authors: macewen eg. Cancer Biother. 1995 Summer;10(2):125-30. doi: 10.1089/cbr.1995.10.125. Cancer Biother. 1995. PMID: 7663571 Clinical Trial.

4

Current studies of liposome muramyl tripeptide (CGP 19835A lipid) therapy for metastasis in spontaneous tumors: a progress review.

MacEwen EG, Kurzman ID, Helfand S, Vail D, London C, Kisseberth W, Rosenthal RC, Fox LE, Keller ET, Obradovich J, et al. MacEwen EG, et al. J Drug Target. 1994;2(5):391-6. doi: 10.3109/10611869408996814. J Drug Target. 1994. PMID: 7704483 Clinical Trial.

5

Induction of serum tumor necrosis factor-alpha and interleukin-6 activity by liposome-encapsulated muramyl tripeptide-phosphatidylethanolamine (L-MTP-PE) in normal cats.

Fox LE, King RR, Shi F, Kurzman ID, MacEwen EG, Kubilis PS. Fox LE, et al. Among authors: macewen eg. Cancer Biother. 1994 Winter;9(4):329-40. doi: 10.1089/cbr.1994.9.329. Cancer Biother. 1994. PMID: 7719380

6

Muramyl peptides augment the in vitro and in vivo cytostatic activity of canine plastic-adherent mononuclear cells against canine osteosarcoma cells.

Smith BW, Kurzman ID, Schultz KT, Czuprynski CJ, MacEwen EG. Smith BW, et al. Among authors: macewen eg. Cancer Biother. 1993 Summer;8(2):137-44. doi: 10.1089/cbr.1993.8.137. Cancer Biother. 1993. PMID: 7804354

7

In vitro and in vivo canine mononuclear cell production of tumor necrosis factor induced by muramyl peptides and lipopolysaccharide.

Kurzman ID, Shi F, MacEwen EG. Kurzman ID, et al. Among authors: macewen eg. Vet Immunol Immunopathol. 1993 Sep;38(1-2):45-56. doi: 10.1016/0165-2427(93)90112-h. Vet Immunol Immunopathol. 1993. PMID: 8256437

8

In vitro and in vivo effect of doxorubicin combined with liposome-encapsulated muramyl tripeptide on canine monocyte activation.

Shi F, MacEwen EG, Kurzman ID. Shi F, et al. Among authors: macewen eg. Cancer Res. 1993 Sep 1;53(17):3986-91. Cancer Res. 1993. PMID: 8358727

9

In vitro and in vivo production of interleukin-6 induced by muramyl peptides and lipopolysaccharide in normal dogs.

Shi F, Kurzman ID, MacEwen EG. Shi F, et al. Among authors: macewen eg. Cancer Biother. 1995 Winter;10(4):317-25. doi: 10.1089/cbr.1995.10.317. Cancer Biother. 1995. PMID: 8590897

10

Canine osteosarcoma: amputation and chemoimmunotherapy.

MacEwen EG, Kurzman ID. MacEwen EG, et al. Vet Clin North Am Small Anim Pract. 1996 Jan;26(1):123-33. doi: 10.1016/s0195-5616(96)50011-2. Vet Clin North Am Small Anim Pract. 1996. PMID: 8825571 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

111 results

Search Page

Filters